Yuki Kataoka
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 26, 2026
TAS3351 is a brain penetrable EGFR-TKI that overcomes T790M and C797S resistant mutations.Hidefumi Kasuga, Yuki Kataoka, Fuyuki Yamamoto
|May 30, 2020
DNA Replication Stress Induced by Trifluridine Determines Tumor Cell Fate According to p53 Status.Yuki Kataoka, Makoto Iimori, Ryo Fujisawa
|May 30, 2019
Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level.Yuki Kataoka, Makoto Iimori, Shinichiro Niimi
|Jun 06, 2018
Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity.Keitaro Edahiro, Makoto Iimori, Takashi Kobunai
Pageof 1
